Company Listing
Lorantis

Lorantis discovered and developed breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company was acquired by Celldex Therapeutics in October 2005.

BACK
Location
Cambridge, UK

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Lorantis discovered and developed breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company was acquired by Celldex Therapeutics in October 2005.

Location
Cambridge, UK
BACK
 
Copyright Abingworth 2017